(888) 391-1315



Special Federal Court Created for Antibiotic Nerve Damage Lawsuits

Wednesday, August 26, 2015

DrugNews reported in May on the growing concern about permanent nerve damage caused by modern synthetic antibiotics. Now, a report shows that with the rising number of lawsuits from those patients affected, a judicial panel has created a multidistrict court to handle the volume.

The drugs Cipro, Avelox and Levaquin are all part of a class of man-made antibiotics called fluoroquinolones. Originally developed in the 1970s, quinolones have been updated several times in recent decades to maintain effectiveness.

Read More

New Report Warns of Blood Disorders and TB from Some Rheumatoid Arthritis Drugs

Friday, August 21, 2015

Rheumatoid arthritis is a chronic disease of the immune system that affects nearly 1% of all adults with painful joints. Since its effects are best managed with medication, this has netted a multi-billion dollar segment for drug manufacturers.

However, a new report shows the growth of these drugs may present a whole new risk of side effects, including blood disorders and tuberculosis.

Read More

New Lawsuits Allege Eliquis Makers Hid Blood Thinner's Dangers

Thursday, August 13, 2015

August 11, 2015 - For several years now, the popular atrial fibrillation drug Eliquis has enjoyed safe status from litigation, while its chief rivals Pradaxa and Xarelto faced over 10,000 claims alleging patients were hospitalized or killed from internal bleeding.

Much of the calm around Eliquis stemmed from clinical studies reportedly showing it was the safest of the three, less likely to cause patient injury or death, and much safer than the traditional alternative warfarin.

Read More

FDA to Reexamine Essure Birth Control Safety After Spike in Complaints

Tuesday, July 07, 2015

July 7, 2015 - The FDA announced last week it will take a new look at the safety of the permanent birth control implant Essure, after a dramatic rise in the number of side effects reported by patients.

Essure is a small flexible metal coil that is implanted in the fallopian tubes through the cervix and uterus in a non-surgical procedure called hysteroscopic sterilization. Within three months, scar tissue grows around the device, blocking the production of new eggs.

Read More

FDA Tells Drug Companies to Lose the Fine Print in Magazine Ads

Wednesday, June 17, 2015

When was the last time you read the fine print on a prescription drug, much less the two pages of boring clinical data that follows each drug advertisement in magazines? If you’re like most people, you skip right past.

The FDA knows this, and they’re now changing their tune to get manufacturers to focus on less, but more important data information in their drug ads.

Read More

New Study Links Gastric Reflux Medications to Heart Attacks

Friday, June 12, 2015

A new study out this month suggests that a popular class of drugs known as proton pump inhibitors used by millions of people daily may contribute to heart attacks and cardiovascular death.

The results were released this week in the online journal Public Library of Science, or PLOS One. Researchers based at Stanford University tracked more than 16 million medical records from 2.9 million patients.

Read More

New Cases Allege Antibiotics Failed to Warn of Serious Nerve Damage

Tuesday, June 09, 2015

A class of antibiotics relied on for years for serious infections are being overused, says a consumer group advocating for tougher warnings from the FDA. And now, with numerous cases surfacing of patients suffering nerve damage, some are filing lawsuits against the drug makers.

Fluoroquinolones are synthetic antibiotics designed to be used in cases of serious infection. The precursor to these, quinolones, have been in use since the late 1970s. Since then, they have undergone at least four generational evolutions to maintain effectiveness and name brand protection against generics.

Read More

New Pradaxa Lawsuits Expected in 2015 for Those Left Out of Prior Settlement

Thursday, May 07, 2015

When the dust settled last May on years of litigation over bleeding risks from the blockbuster anticoagulant Pradaxa, German manufacturer Boehringer Ingelheim had agreed to pay $650 million to compensate around 4,000 patients and surviving family members.

The problem with the settlement, legal experts pointed out, was that Pradaxa was still being prescribed to millions of new patients with little warning of the potential for internal bleeding. And, those hospitalized after May 2014 would not receive compensation.

Not fair, said a group of leading drug injury law firms, who have commenced plans to start new Pradaxa litigation in a different court this year.

Read More

Doctors Still Recommending Hysterectomy Morcellators Had Financial Interest

Friday, February 20, 2015

Last year, news broke that power morcellator surgical devices used in hundreds of thousands of hysterectomies could cause the spread of deadly uterine cancer, and that 1 in 350 women could be affected.

Most of the involved parties acted swiftly to limit the risk to future patients: major surgical centers announced they were halting use of the devices; the FDA recommended limiting their use; and the largest manufacturer of the machines stopped selling them.

Read More

Man Awarded $2.3 Million for Bladder Cancer From Diabetes Drug Actos

Friday, February 13, 2015

A Pennsylvania jury this week ruled that a retired teacher’s bladder cancer was caused in large part by the diabetes medication Actos, and that the maker of the drug had not properly warned he or his doctor of the dangers.

The decision is the latest warning to consumers over the safety of Actos, which was once the most popular drug in the world for treating type-2 diabetes. Japanese drug maker Takeda continues to claim it is safe, although they now face over 7,500 patient lawsuits for bladder cancer.

Read More

prev 1 2 3 4 5 6 next